Trial Profile
A Multi-center, Phase III, Non-controlled, Open-label Trial to Evaluate the Safety and Efficacy of SCT800 for On-demand Treatment in Previously Treated Patients With Hemophilia A
Status:
Not yet recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Omfiloctocog alfa (Primary)
- Indications Haemophilia A
- Focus Pharmacokinetics
- Sponsors Sinocelltech
- 05 Oct 2016 New trial record